Gleason Group’s Cano Health, Inc. CANO Stock Holding History

Gleason Group’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-65	Closed	-$56K	–	240
2022 Q3	$56K	Hold	65	–	–	0.02%	104
2022 Q2	$28K	Hold	65	–	–	0.01%	135
2022 Q1	$41K	Buy	+65	New	+$41K	0.01%	125

Other funds holding CANO

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Gleason Group's CANO Position: Q4 2022 in Review

Gleason Group sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 65 shares — an estimated $56K sold.

Gleason Group first reported a position in CANO in Q1 2022 and held it in 3 quarters. The position peaked at $56K in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

Gleason Group reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
Gleason Group sold 65 Cano Health, Inc. shares in Q4 2022, an estimated $56K.
Gleason Group first reported a position in Cano Health, Inc. in Q1 2022 and held it in 3 quarters.
Gleason Group's Cano Health, Inc. position peaked at $56K in Q3 2022.
186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Gleason Group's 13F filing for Q4 2022, filed 11 Jan 2023.